NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome.
Armstrong, Christopher W, McGregor, Neil R, Sheedy, John R et al. · Clinica chimica acta; international journal of clinical chemistry · 2012 · DOI
Quick Summary
Researchers used a specialized blood test called NMR to compare the levels of different chemicals in the blood of 11 people with ME/CFS and 10 healthy people. They found that people with ME/CFS had significantly lower levels of two amino acids (building blocks of protein): glutamine and ornithine. These findings suggest that people with ME/CFS may have problems with how their bodies process certain proteins and manage nitrogen, which are important for energy and cell function.
Why It Matters
This study provides objective biochemical evidence that ME/CFS involves measurable metabolic abnormalities, particularly in amino acid and nitrogen metabolism. If validated in larger cohorts, identifying specific metabolic biomarkers could improve diagnostic accuracy and help distinguish ME/CFS from other conditions, potentially advancing both patient diagnosis and research into disease mechanisms.
Observed Findings
Glutamine levels were significantly reduced in CFS serum compared to controls (P=0.002)
Ornithine levels were significantly reduced in CFS serum compared to controls (P<0.05)
Glutamine and ornithine correlated with glucogenic amino acids in CFS samples
Metabolic disturbances were linked to metabolites involved in the urea cycle
These alterations were not present in control subjects
Inferred Conclusions
Amino acid and nitrogen metabolism are disturbed in people with ME/CFS
Glutamine and ornithine may serve as potential biomarkers for CFS diagnosis
The urea cycle and gluconeogenesis may be involved in CFS pathophysiology
Objective metabolic abnormalities can be detected in CFS blood samples using NMR profiling
Remaining Questions
Do these metabolic abnormalities cause ME/CFS symptoms, or are they consequences of the disease?
Can glutamine and ornithine levels reliably distinguish ME/CFS from other fatigue-causing conditions in larger populations?
What This Study Does Not Prove
This study does not prove that low glutamine and ornithine cause ME/CFS or explain how these metabolic changes relate to specific symptoms like post-exertional malaise or cognitive dysfunction. It is a small preliminary study, so findings must be replicated in larger populations before they can be used clinically. Correlation between these amino acids and other metabolites does not establish the biochemical pathways responsible for the disturbances.